Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies
NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC
Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects
Controlling Diabetes May Cut Liver Cancer Risk, Study Finds
Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds
Healthcare Utilization Figures More Than Biology In Disparity
Phase III Lung and Pancreatic Cancer Trials Are Stopped
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
